Increasing cost of medicines

Erratum: Who Will Fund Postgraduate Education after 1992?

Journal of the Royal College of Physicians of London·2019

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

Kidney international·2006

Venetian treacle and the foundation of medicines regulation.

British journal of clinical pharmacology·2004

Hertfordshire medieval hospitals.

Adverse drug reactions and toxicological reviews·2001

Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression.

Journal of cellular physiology·2000

Immunolocalization of stress proteins and extracellular matrix proteins in the rat tibia.

Tissue & cell·2000

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study.

Dermatology and therapy·2026

Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.

Clinical parkinsonism & related disorders·2026

Brain-targeted intranasal aripiprazole via modified chitosan nanoparticles: controlled release, pharmacokinetics, and pharmacodynamics.

Drug delivery and translational research·2026

Dopamine D2 receptor dependent and independent structural, intrinsic and synaptic adaptations in experimental parkinsonism.

Neurobiology of disease·2026

Microfluidic-assisted formulation of hydrophobic ion pairing-Based solid lipid nanoparticles for semaglutide delivery.

International journal of pharmaceutics·2026

Microfluidic nano-in-microcapsules for ph-responsive colonic delivery of 5-ASA: A moving-boundary kinetic approach.

Colloids and surfaces. B, Biointerfaces·2026

Related Experiment Videos

Increasing cost of medicines

Related Concept Videos

Erratum: Who Will Fund Postgraduate Education after 1992?

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

Venetian treacle and the foundation of medicines regulation.

Hertfordshire medieval hospitals.

Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression.

Immunolocalization of stress proteins and extracellular matrix proteins in the rat tibia.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study.

Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.

Brain-targeted intranasal aripiprazole via modified chitosan nanoparticles: controlled release, pharmacokinetics, and pharmacodynamics.

Dopamine D2 receptor dependent and independent structural, intrinsic and synaptic adaptations in experimental parkinsonism.

Microfluidic-assisted formulation of hydrophobic ion pairing-Based solid lipid nanoparticles for semaglutide delivery.

Microfluidic nano-in-microcapsules for ph-responsive colonic delivery of 5-ASA: A moving-boundary kinetic approach.

Related Experiment Videos

Increasing cost of medicines

Related Concept Videos

Related Articles